<?xml version="1.0" encoding="UTF-8"?>
<p id="p0055">Finally, although the cardiovascular side effects of the current drugs empirically used for the Covid-19 infection and now tested in experimental protocols (such as anti-viral–remdisivir or lopinavir+ritonavir– or anti-leukin 6 –tocilizumab– or other antinflammatory –chloroquine–) are rare and not serious, an active surveillance is mandatory.</p>
